IL17A and gastric cancer: IL-17a secretion by CAFs markedly enhances tumorigenic effects of gastric cancer through the JAK2/STAT3 pathway in the gastric cancer cells in vitro, with CAFs acting as an independent risk factor for DFS and DSS, as noted above [215].